China Resources Double-Crane Pharmaceutical (SHA:600062) obtained drug registration from China's medical products administrator for its compound polyethylene glycol electrolytes powder.
The drug is used to treat chronic constipation and fecal impaction in children, according to a Thursday filing with the Shanghai bourse.
Shares of the pharmaceutical company were up 1% Thursday.